Simon, M.; Lücht, C.; Hosp, I.; Zhao, H.; Wu, D.; Heidecke, H.; Witowski, J.; Budde, K.; Riemekasten, G.; Catar, R.
Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells. Int. J. Mol. Sci. 2021, 22, 11793.
https://doi.org/10.3390/ijms222111793
AMA Style
Simon M, Lücht C, Hosp I, Zhao H, Wu D, Heidecke H, Witowski J, Budde K, Riemekasten G, Catar R.
Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells. International Journal of Molecular Sciences. 2021; 22(21):11793.
https://doi.org/10.3390/ijms222111793
Chicago/Turabian Style
Simon, Michèle, Christian Lücht, Isa Hosp, Hongfan Zhao, Dashan Wu, Harald Heidecke, Janusz Witowski, Klemens Budde, Gabriela Riemekasten, and Rusan Catar.
2021. "Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells" International Journal of Molecular Sciences 22, no. 21: 11793.
https://doi.org/10.3390/ijms222111793
APA Style
Simon, M., Lücht, C., Hosp, I., Zhao, H., Wu, D., Heidecke, H., Witowski, J., Budde, K., Riemekasten, G., & Catar, R.
(2021). Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells. International Journal of Molecular Sciences, 22(21), 11793.
https://doi.org/10.3390/ijms222111793
